Flow cytometry has emerged as a key tool for exploratory research during drug discovery and development processes. It has the ability to analyze a large number of particles in a short period of time and to provide statistically robust information about the cell population. Flow cytometry method helps to subclassify cell types to decide on the best treatment plan. It can also detect residual levels of disease after treatment. The growing number of clinical trials and increasing focus on developing novel therapeutics to address the rising disease burden are expected to contribute to the growth of the flow cytometry market during the forecast period. —
The development of advanced flow cytometry products has brought increased automation, ease of use, and more accurate analysis for various research and clinical uses. Also, the discoveries in stem cell biology have amplified the importance of pluripotent stem cells in therapeutics and have improved researchers’ understanding of normal and disease processes. The evolving pipeline for stem cell research is creating growth opportunities for players to develop effective flow cytometry methods with the ability to investigate large cell populations at the single-cell level in stem cell research. Meticulous Research® in its latest publication on flow cytometry market states that the global flow cytometry market is expected to grow at a CAGR of around 6.5% from 2019 to 2027 to exceed $4.1 billion by 2027.
The growth of the global flow cytometry market is mainly attributed to the rising global incidence and prevalence of chronic diseases, such as HIV-AIDS and cancer, increasing adoption of flow cytometry techniques in research and academia, and growing focus on immunology and immuno-oncology research. In addition, evolving pipeline for stem cell research and adoption of recombinant DNA technology for antibody production are further expected to provide significant opportunities for the various stakeholders in this market. However, high product costs are likely to hinder the market growth. On the other hand, inadequate research infrastructure across emerging countries and complexities related to development of the reagents for flow cytometry procedure are some of the key challenges for players in this market.
To provide efficient analysis, Meticulous Research® has segmented this market by Product & Solution (Consumables, Systems, Software, Service), by Technology (Cell & Bead Based), by Application (Research, Clinical, Industrial), End-user (Academic & Research Institute, Hospitals & Clinical Testing Labs, Pharmaceutical & Biotechnology Companies), and Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa).
Request Exclusive Free Sample PDF Of This Report At:https://www.meticulousresearch.com/request-sample-report/cp_id=5067
Geographically, North America commanded the largest share of the global flow cytometry market in 2018, closely followed by the Europe, and Asia Pacific. However, Asia Pacific region is slated to register fastest growth during the forecast period primarily due to the increasing participation by China, India, Japan, and South Korea in flow cytometry-based research and increasing public-private initiatives undertaken to advance the research practices in this region.
Based on technology, the bead-based flow cytometry segment is expected to grow at the highest CAGR during the forecast period. This is mainly attributed to the procedural advantages offered by this technology over other cell-based technology (such as ELISA and western blot), including its capacity to detect multiple analytes, high reproducibility, stability, and speed.
The report provides competitive intelligence in terms of financials, growth strategies, product portfolios, and geographical presence on some of the key players in this market including Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Apogee Flow Systems Ltd. (U.K.), Merck KGaA (Germany), Sysmex Partec GmbH (Germany), Luminex Corporation (U.S.), Miltenyi Biotec GmbH (Germany), Bio-Rad Laboratories, Inc. (U.S.), bioMérieux S.A. (France), Cytonome/ST LLC (U.S.), Beckman Coulter, Inc. (U.S.), and Becton, Dickinson and Company (U.S.).
Download Sample Report Here:https://www.meticulousresearch.com/download-sample-report/cp_id=5067
Key Topics Covered in This Report:
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
2.1.2. Primary Research
2.1.3. Market Size Estimation
3. Executive Summary
4. Market Insights
4.2.1. Rising Global Incidence and Prevalence of Chronic Diseases
4.2.2. Increasing Adoption of Flow Cytometry Techniques in Research and Academia
4.2.3. Growing Initiatives in the Field of Immunology and Immuno-Oncology Researches
4.2.4. Technological Advancements
4.3.1. Lack of Skilled Professionals
4.3.2. Significant Product Costs
4.4.1. Evolving Pipeline for Stem Cell Research
4.4.2. Adoption of Recombinant DNA Technology for Antibody Production
4.5.1. Inadequate Research Infrastructure Across Emerging Countries
4.5.2. Complexities Related to Reagent Development
5. Global Flow Cytometry Market, by Technology
5.2. Cell-Based Flow Cytometry
5.3. Bead-Based Flow Cytometry
6. Global Flow Cytometry Market, by Product & Solution
6.2. Consumables and Accessories
6.3.1. Cell Analyzers
6.3.2. Cell Sorters
7. Global Flow Cytometry Market, by Application
7.2. Research Applications
7.2.1. Drug Discovery
7.2.2. Stem Cell Research
7.2.3. Other Research Application
7.3. Clinical Applications
7.3.2. Organ Transplantation
7.3.3. Other Clinical Applications
7.4. Industrial Applications
8. Global Flow Cytometry Market, by End User
8.2. Academic & Research Institutes
8.3. Hospitals & Clinical Testing Laboratories
8.4. Pharmaceutical & Biotechnology Companies
8.5. Other End Users
....To Read More TOC Click Here
Email: Send Email
Organization: Meticulous Market Research Pvt. Ltd.
Release ID: 88942543